title: Comparative mechanisms of 4-aminopyridine-resistant Ito in human and rabbit atrial myocytes.
abstract: The cardiac transient outward current (Ito) has been shown in several species to consist of two components: 1) a 4-aminopyridine (4-AP)-sensitive component (Ito1) and 2) a 4-AP-resistant component (Ito2). In rabbits, Ito2 is a Ca(2+)-dependent Cl- current [ICl(Ca)]; similar mechanisms have been suggested to underlie Ito2 in human atrium. We used whole cell patch-clamp techniques to define the mechanism of Ito2 (defined as the component resistant to 5 mM 4-AP) in human atrial myocytes, with parallel experiments performed in rabbit atrial cells. In rabbit atrium, Ito2 activated more slowly than Ito1 and had a bell-shaped current-voltage of Ito with properties similar to Ito2 in the rabbit, and a similar component recorded with pipette K+ replaced by Cs+ was suppressed by the substitution of methanesulfonate for Cl- in the superfusate. In human cells, a 4-AP-resistant Ito2 was recorded at a depolarizing pulse frequency of 1 Hz, but not at 0.1 Hz. Ito2 activated rapidly and inactivated earlier than Ito1, whereas its I-V relation was linear like that of Ito1. Ryanodine had no effect on human atrial Ito. When K(+)-free pipette solutions were used, no Ito was recorded in 30 human atrial myocytes, and external Cl- replacement with methanesulfonate failed to reveal an Ito. In 13 human myocytes, isoproterenol increased ICa but failed to activate an Ito compatible with ICl(Ca). Whereas caffeine suppressed human atrial Ito, it also suppressed Ito1 [in the presence of 200 microM Cd2+ to block ICa and 5 mM intracellular ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid to buffer intracellular Ca2+] in both human and rabbit atrium, indicating an action unrelated to Ca(2+)-triggered Ca2+ release. In conclusion, we were unable to demonstrate the presence of ICl(Ca) in human atrial myocytes, and the 4-AP-resistant component of Ito appeared to be due to 4-AP unblocking.
authors.affiliation: Department of Medicine, Montreal Heart Institute, University of Montreal, Quebec, Canada.
authors.forename: G R
authors.initials: GR
authors.lastname: Li
authors.forename: J
authors.initials: J
authors.lastname: Feng
authors.forename: Z
authors.initials: Z
authors.lastname: Wang
authors.forename: B
authors.initials: B
authors.lastname: Fermini
authors.forename: S
authors.initials: S
authors.lastname: Nattel
mesh_terms: D015761:4-Aminopyridine / Q000494:pharmacology*; D000818:Animals; D016275:Atrial Function / Q000187:drug effects*; D002110:Caffeine / Q000494:pharmacology; D002118:Calcium / Q000502:physiology; D002712:Chlorides / Q000502:physiology; D004351:Drug Resistance; D004594:Electrophysiology; D006801:Humans; D009206:Myocardium / Q000166:cytology; D018408:Patch-Clamp Techniques; D015221:Potassium Channels / Q000502:physiology; D011817:Rabbits
chemical_list: D002712:Chlorides; D015221:Potassium Channels; D002110:Caffeine; D015761:4-Aminopyridine; D002118:Calcium